Viewing Study NCT02939820


Ignite Creation Date: 2025-12-25 @ 4:07 AM
Ignite Modification Date: 2026-05-27 @ 3:13 PM
Study NCT ID: NCT02939820
Status: APPROVED_FOR_MARKETING
Last Update Posted: 2024-05-20
First Post: 2016-10-18
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: Expanded Access Protocol of Patisiran for Patients With Hereditary ATTR Amyloidosis (hATTR)
Sponsor: Alnylam Pharmaceuticals
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Description Module Conditions Module Design Module Arms Interventions Module Eligibility Module Contacts Locations Module References Module